Achieve Life Sciences (NASDAQ:ACHV) reported quarterly losses of $(0.83) per share which met the analyst consensus estimate. This is a 9.21 percent decrease over losses of $(0.76) per share from the same period last year.
Argus Research Upgrades Comerica to Buy, Announces $87 Price Target
Argus Research analyst Kevin Heal upgrades Comerica (NYSE:CMA) from Hold to Buy and announces $87 price target.